摘要
目的探讨肾血管周上皮样细胞肿瘤(PEComa)的临床特点。方法回顾性分析2013年1月至2020年12月中山大学附属第一医院收治的10例肾PEComa患者的临床资料。所有患者均经外科手术治疗,术后标本均行病理学及免疫组化检测,术后随访采用门诊及电话随访相结合。结果10例患者中,5例行肾部分切除术,5例行根治性肾切除术。10例患者最终病理诊断均为肾PEComa,8例免疫组化染色检查示HMB45阳性,8例Melan-A阳性,8例Actin灶性阳性,6例Vimentin阳性,2例Desmin阳性,1例CD34阳性,1例S-100阳性,Ki-67呈不同程度表达(1%~5%)考虑为阴性。10例患者随访时间16~78个月,除1例患者不明原因死亡外,其余患者均未见转移或复发。结论肾PEComa临床上少见,特征不明显,影像学检查难以确诊,病理为诊断金标准,行手术切除后大多数均预后较好。
Objective To investigate the clinical features of perivascular epithelioid cell tumor(PEComa).Methods The clinical data of 10 patients with renal PEComa admitted to the First Affiliated Hospital of Sun Yat-sen University during Jan.2013 and Dec.2020 were retrospectively analyzed.All patients underwent surgical treatment.Pathological and immunohistochemical examinations were performed on postoperative specimens.Postoperative follow-up was conducted by outpatient department and telephone.Results Partial nephrectomy was performed in 5 cases,and radical nephrectomy in 5 cases.The final pathological diagnosis of all patients was renal PEComa.Immunohistochemical staining showed HMB45 positive in 8 cases,Melan-A positive in 8 cases,focal Actin positive in 8 cases,Vimentin positive in 6 cases,Desmin positive in 2 cases,CD34 positive in 1 case,and S-100 positive in 1 case.Ki-67 was expressed in different degrees(1%-5%).During the follow-up of 16 to 78 months,1 patient died of unknown causes,and no metastases or recurrences were observed.Conclusion As a rare disease,renal PEComa has no obvious features and is difficult to be diagnosed by imaging examination.Pathology is the gold standard for diagnosis,and most patients have good prognosis after surgical resection.
作者
陈景勉
莫承强
王妙燕
关键烽
CHEN Jingmian;MO Chengqiang;WANG Miaoyan;GUAN Jianfeng(Department of Urology,Lianjiang People s Hospital of Guangdong Province,Lianjiang 524400;Department of Urology,First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510000,China)
出处
《现代泌尿外科杂志》
CAS
2021年第9期767-769,784,共4页
Journal of Modern Urology
关键词
肾血管周上皮样细胞肿瘤
诊断
治疗
预后
随访
renal perivascular epithelioid cell tumor
diagnosis
treatment
prognosis
follow-up